FDA re­jects Cy­to­ki­net­ic­s' heart fail­ure drug, but the biotech has a back­up

The FDA re­ject­ed Cy­to­ki­net­ics’ lead can­di­date for heart fail­ure, say­ing the com­pa­ny didn’t pro­vide enough ev­i­dence of the drug’s ef­fi­ca­cy.
Cy­to­ki­net­ics

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER